Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Transition Therapeutics Inc    TTH   CA8937162094

 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
08/19/2016 08/22/2016 08/23/2016 08/25/2016 08/26/2016 Date
2.04 2.06 2.02 2.02 1.92 Last
1900 400 700 500 180 Volume
0.00% +0.98% -1.94% 0.00% -4.95% Change
Financials ( CAD)
Sales 2016 -
EBIT 2016 -
Net income 2016 -
Debt 2016 -
Yield 2016 -
Sales 2017 -
EBIT 2017 -
Net income 2017 -
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 0
Capi. / Sales2017 0
Capitalization 74,5 M
More Financials
Company
Transition Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapeutics for disease indications with large markets.It operates through research and development of therapeutic agents segment.The company's products include ELND005 for the treatment of alzheimer's... 
Sector
Pharmaceuticals
Calendar
09/13Earnings Release
More about the company
Latest news on TRANSITION THERAPEUTICS IN
08/26 TRANSITION THERAPEUTICS : Announces Special Shareholder Meeting Voting Results I..
06/03 TRANSITION THERAPEUTICS : Receives Notification From NASDAQ
05/11 TRANSITION THERAPEUTICS : Announces Third Quarter Fiscal 2016 Financial Results
05/09 TRANSITION THERAPEUTICS TO HOLD CONF : 30 p.m. est
04/18 TRANSITION THERAPEUTICS : Provides Update on Type 2 Diabetes Drug Candidate TT40..
03/17 TRANSITION THERAPEUTICS : Receives Notification From NASDAQ
03/01 TRANSITION THERAPEUTICS : to Present at the 36th Annual Cowen Healthcare Confere..
02/09 TRANSITION THERAPEUTICS : Announces Second Quarter Fiscal 2016 Financial Results
02/05 TRANSITION THERAPEUTICS : to Hold Conference Call on Second Quarter Fiscal 2016 ..
02/01 TRANSITION THERAPEUTICS : Announces Top Line Phase 2 Clinical Study Results of D..
More news
Sector news : Biopharmaceuticals
09:29aDJSANOFI : Regeneron Announce Positive Trials for Cholesterol Drug
08/27 Stada shareholder AOC pushes through board reshuffle
08/27 ABBOTT LABORATORIES : Whiplashed investors stay skittish about St. Jude
08/26 MUDDY WATERS SAYS ST. JUDE SHARES CO : Cnbc
08/26DJST JUDE MEDICAL : . Jude Denies Claims in Muddy Waters Report
More sector news : Biopharmaceuticals
News from SeekingAlpha
08/26 Transition Therapeutics shareholders back OPKO merger
06/30 OPKO buys Transition Therapeutics in all-stock deal
06/03 Bayer expands development program for prostate cancer candidate BAY-1841788 w..
05/11 Transition Therapeutics' (TTHI) CEO Chip Brewer on Q3 2016 Results - Earnings..
05/11 Transition Therapeutics reports FQ3 results
Advertisement
Chart TRANSITION THERAPEUTICS IN
Duration : Period :
Transition Therapeutics In Technical Analysis Chart | TTH | CA8937162094 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 2,38  CAD
Spread / Average Target 24%
Consensus details
Managers
NameTitle
Tony F. Cruz Chairman & Chief Executive Officer
Carl Damiani President & Chief Operating Officer
Nicole Rusaw-George Chief Financial Officer
Aleksandra Pastrak VP-Clinical Development & Medical Officer
Michael Richard Dwyer Ashton Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
TRANSITION THERAPEUTIC..-25.29%57
CSL LIMITED3.55%37 907
ALEXION PHARMACEUTICAL..-32.04%29 069
GRIFOLS SA-10.42%13 294
BEIJING TIANTAN BIOLOG..12.63%3 041
JIANGXI BOYA BIO-PHARM..--.--%2 698
More Results